The weekend after Thanksgiving 2005 I will be speaking at a seminar in Cozumel that will be of particular interest if you want to scuba dive.

The seminar is sponsored by the Bench Bar Committee of the Tennessee Judicial Conference. Attendees will stay at the Fiesta Americana, an all-inclusive resort.

I will be speaking for 6 hours (3 hours per day) on Saturday and Sunday. Three hours will address tort and comparative fault issues and three hours will be an indepth look at the law of depositions. CLE credit will be available. The sessions will be interactive.

There are many ways that defendants fight medical negligence cases. Some battles are fought in the courtroom. Some are fought in the Legislature. Others are fought against the doctors who choose to testify for plaintiffs.

Read this article about what can happen if a group of doctors doesn’t like your expert’s testimony.

I am familiar with the Fullerton case mentioned in the article; I sit on an ATLA Committee that advises the Center for Constitutional Litigation that is advising Dr. Fullerton. I will let you know when that case is resolved.

There is a new study out that maintains that relatively minor changes in highway design can say lives.

The study, by the Insurance Information Institute, explains that “urban roads ‘weren’t built to accommodate today’s heavy traffic. They’ve evolved as traffic has increased, and they haven’t always evolved in the best way to enhance safety and ensure a smooth flow of traffic.'” A news report about the study says that “the majority of traffic fatalities happen on rural roads, but safety experts say urban arteries remain dangerous. About 8,000 traffic fatalities and more than 1 million injuries occur annually on urban roads.”

The article gives several examples of how spending a relatively small amount of money can improve safety.

The NYT has done a review of the testimony to date in the Texas Vioxx trial. The Times concludes that the plaintiff has the upper hand, which one would hope would be true since the defense has not put on its case yet but is still good news for the plaintiff.

The article reviews some of the testimony. For example, consider this excerpt:

Mr. Lanier later asked Dr. Nies [a retired Merck scientist involved in the Vioxx project] about a contract proposal in which Merck had offered to pay researchers at Harvard $200,000 to lead a study that would have directly examined Vioxx’s heart risks. Dr. Nies said the study would have been unethical, which is why the study was ultimately scrapped.

The Plaintiff closed her case yesterday in the Texas Vioxx trial, and Merck called its first witness, a researcher.

One of Merck’s arguments is that the decedent was a smoker. His widow testified that he had not smoked in 15 years.

I assume that Merck has at least one defense better than that one.

Remember the anthrax scare in the months following the 9/11 attacks? Remember Mr. Z? If you don’t, this opinion will refresh your recollection.

Mr. Z was named in some New York Times articles and did not appreciate being called a terrorist. He sued, had his case dismissed, but the Fourth Circuit Court of Appeals reversed and remanded the case for trial.

He will get his day in court. I wonder if the NYT will be forced to reveal its source(s) for the stories?

Do you have a potential case where you need to know something about a chemical substance? Look first to MSDS – Material Safety Data Sheets. These documents may be found here.

MSDS have lots of information, including …

Section 1 – Product and Company Identification
Section 2 – Compositon/Information on Ingredients
Section 3 – Hazards Identification Including Emergency Overview
Section 4 – First Aid Measures
Section 5 – Fire Fighting Measures
Section 6 – Accidental Release Measures
Section 7 – Handling and Storage
Section 8 – Exposure Controls & Personal Protection
Section 9 – Physical & Chemical Properties
Section 10 – Stability & Reactivity Data
Section 11 – Toxicological Information
Section 12 – Ecological Information
Section 13 – Disposal Considerations
Section 14 – MSDS Transport Information
Section 15 – Regulatory Information
Section 16 – Other Information

Contact Information